Live tape
Mentions 7d10,658MSFT2,129 mentions▲ +0.05META1,824 mentions▲ +0.06NVDA1,611 mentions▲ +0.09SKHYY1,176 mentions▲ +0.08GOOGL1,167 mentions▲ +0.04QQQ960 mentions▲ +0.06SNDK900 mentions▲ +0.08SPY891 mentions▲ +0.03
Equity · Healthcare

CADL

CADL · NasdaqGM
Price · Chart Chart by TradingView
Track this symbol on TradingView

Crowd sentiment on CADL · 30d

Method · 0 mentions
Bullish 0%
Neutral 100%
Bearish 0%

Across 0 classified mentions in the last 30 days, crowd sentiment for CADL sits roughly neutral, with 0% reading bullish against 0% bearish across the classified sample.

CADL insider trades

SEC Form 4
Date Insider Type Shares Value
28 Jul 2025 Nichols William Garrett Chief Medical Officer SELL 937 $7K
28 Jul 2025 Nichols William Garrett Chief Medical Officer OPTION EXERCISE 937 $1K
30 Jun 2025 Nichols William Garrett Chief Medical Officer SELL 781 $4K
30 Jun 2025 Nichols William Garrett Chief Medical Officer OPTION EXERCISE 781 $1K
25 Jun 2025 Barone Francesca Chief Scientific Officer AWARD 4,282 $20K
25 Jun 2025 Loggia Nicoletta AWARD 2,141 $10K
25 Jun 2025 Martell Christopher AWARD 111,349 $520K
25 Jun 2025 Tak Paul Peter Chief Executive Officer AWARD 42,826 $200K

CADL earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $-0.14 —
31 Dec 2025 FY 2025 $-0.72 —
30 Sep 2025 Q3 2025 $-0.21 —
30 Jun 2025 Q2 2025 $-0.09 —

Reported figures & scheduled dates · SEC EDGAR filings